Toshihiro Nanki

20PUBLICATIONS
35CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Neurology and neuromuscular diseasesMedical parasitologyOrthodontics and dentofacial orthopaedicsInfectious diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Jun 16, 2026
Efficacy of romosozumab followed by denosumab in glucocorticoid users; a randomized clinical trial.

|Dec 15, 2025
Anti-SRP antibody-positive polymyositis complicated by neuromyelitis optica spectrum disorder: a case report and literature review.

Eisuke Tanaka, Mai Kawazoe, Shotaro Masuoka

|Sep 18, 2025
Mepolizumab in patients with eosinophilic granulomatosis with polyangiitis reduced glucocorticoid dose and improved residual symptoms compared to conventional immunosuppressants: a retrospective observational study.

Daiki Sakai, Kaichi Kaneko, Karin Furukawa

|Jun 01, 2025
Long-Term Effectiveness and Safety of Denosumab for Osteoporosis in Patients With Rheumatic Diseases.

Karin Furukawa, Kaichi Kaneko, Mai Kawazoe

|Feb 07, 2025
Development and validation of a prediction model for serious infections in rheumatoid arthritis patients treated with tocilizumab in Japan.

Toshihiro Nanki, Tomohiro Yamaguchi, Kosei Umetsu

|Nov 18, 2024
Comparison of Efficacy of Romosozumab With Denosumab and Risedronate in Patients Newly Initiating Glucocorticoid Therapy.

Mai Kawazoe, Kaichi Kaneko, Shotaro Masuoka

Pageof 4

Frequent Collaborators

8 joint publications

Mai Kawazoe

4 joint publications

Takahiko Sugihara

4 joint publications

Sei Muraoka

3 joint publications

Kaichi Kaneko